P.A. Monici Preti

Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica.

A Maresta, Marco Balducelli, Luca Cantini et al. · Circulation · 1994 · 151 citations · Full text

Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV ‘real life’ trial on the variability of response to opioids

Oscar Corli, Irene Floriani, Mauro Montanari et al. · Annals of Oncology · 2016 · 144 citations · Full text

Pain Therapy, Pain Disorders, Health Sciences +11

A Formulation of Aerosolized Tobramycin (Bramitob??) in the Treatment of Patients with Cystic Fibrosis and Pseudomonas aeruginosa Infection

Eszter Csisz r, K lm n Gyurkovics, Maria Trawi ska Bartnicka et al. · Pediatric Drugs · 2007 · 84 citations

Antimicrobial Susceptibility, Health Sciences, Antimicrobial Chemotherapy +8

Efficacy, Safety, and Local Pharmacokinetics of Highly Concentrated Nebulized Tobramycin in Patients with Cystic Fibrosis Colonized with Pseudomonas aeruginosa

G. Lenoir, Yuriy Genadievich Antypkin, Angelo Miano et al. · Pediatric Drugs · 2007 · 81 citations

Antimicrobial Susceptibility, Cystic Fibrosis Colonized, Pseudomonas Aeruginosa +7

Conjugates of Ara-AMP with Lactosaminated Albumin: A Study on Their Immunogenicity in Mouse and Rat

L. Fiume, P.A. Monici Preti, G. Spinosa · Cancer Drug Delivery · 1987 · 32 citations